GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (NAS:AZTA) » Definitions » Cyclically Adjusted PB Ratio

Azenta (Azenta) Cyclically Adjusted PB Ratio : 2.59 (As of May. 01, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Azenta Cyclically Adjusted PB Ratio?

As of today (2024-05-01), Azenta's current share price is $52.46. Azenta's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $20.23. Azenta's Cyclically Adjusted PB Ratio for today is 2.59.

The historical rank and industry rank for Azenta's Cyclically Adjusted PB Ratio or its related term are showing as below:

AZTA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.9   Med: 2.94   Max: 10.27
Current: 2.63

During the past years, Azenta's highest Cyclically Adjusted PB Ratio was 10.27. The lowest was 0.90. And the median was 2.94.

AZTA's Cyclically Adjusted PB Ratio is ranked worse than
58.55% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs AZTA: 2.63

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Azenta's adjusted book value per share data for the three months ended in Dec. 2023 was $43.857. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $20.23 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Azenta Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Azenta's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta Cyclically Adjusted PB Ratio Chart

Azenta Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.93 4.40 8.55 2.71 2.57

Azenta Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.52 2.54 2.51 2.57 3.22

Competitive Comparison of Azenta's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Azenta's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azenta's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Azenta's Cyclically Adjusted PB Ratio falls into.



Azenta Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Azenta's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=52.46/20.23
=2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Azenta's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Azenta's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=43.857/129.4194*129.4194
=43.857

Current CPI (Dec. 2023) = 129.4194.

Azenta Quarterly Data

Book Value per Share CPI Adj_Book
201403 9.484 99.695 12.312
201406 9.838 100.560 12.661
201409 9.608 100.428 12.382
201412 9.368 99.070 12.238
201503 9.319 99.621 12.106
201506 9.353 100.684 12.022
201509 9.345 100.392 12.047
201512 9.063 99.792 11.754
201603 7.840 100.470 10.099
201606 7.912 101.688 10.070
201609 8.067 101.861 10.250
201612 7.953 101.863 10.105
201703 8.193 102.862 10.308
201706 8.455 103.349 10.588
201709 8.701 104.136 10.814
201712 8.888 104.011 11.059
201803 9.893 105.290 12.160
201806 10.083 106.317 12.274
201809 10.153 106.507 12.337
201812 10.148 105.998 12.390
201903 10.119 107.251 12.211
201906 10.221 108.070 12.240
201909 15.754 108.329 18.821
201912 15.739 108.420 18.787
202003 15.744 108.902 18.710
202006 15.928 108.767 18.952
202009 16.438 109.815 19.373
202012 16.873 109.897 19.870
202103 17.041 111.754 19.735
202106 17.603 114.631 19.874
202109 17.826 115.734 19.934
202112 18.253 117.630 20.082
202203 46.210 121.301 49.303
202206 45.710 125.017 47.320
202209 44.833 125.227 46.334
202212 41.582 125.222 42.976
202303 41.870 127.348 42.551
202306 44.505 128.729 44.744
202309 43.825 129.860 43.676
202312 43.857 129.419 43.857

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Azenta  (NAS:AZTA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Azenta Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Azenta's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Azenta (Azenta) Business Description

Traded in Other Exchanges
Address
200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
Executives
Herman Cueto officer: EVP, Chief Financial Officer C/O AZENTA, INC., 200 SUMMIT DRIVE, 6TH FLOOR, BURLINGTON MA 01803
Violetta Hughes officer: VP, Chief Accounting Officer C/O AZENTA, INC., 200 SUMMIT DRIVE, 6TH FLOOR, BURLINGTON MA 01803
David C Gray officer: Chief Strategy & New Business C/O GT SOLAR INTERNATIONAL, INC., 243 DANIEL WEBSTER HIGHWAY, MERRIMACK NH 03054
Joseph R Martin director
Dorothy E Puhy director DANA FARBER CANCER INSTITUTE, 44 BINNEY STREET, RM. D1632, BOSTON MA 02115
Tina Susan Nova director C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Mitchell Coyne officer: SVP and GM, Life Sciences Proj 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Ginger Zhou officer: SVP and General Manager, Genom 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Matthew Mcmanus officer: EVP & Chief Operating Officer 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Lindon G Robertson officer: EVP & Chief Financial Officer C/O GRAFTECH INTERNATIONAL LTD., 12900 SNOW ROAD, PARMA OH 44130
Kimberly Crowley officer: Chief Human Resources Officer 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Vandana Sriram officer: VP, Finance & Corp. Controller 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Jesus Linda De officer: Chief Commercial Officer, LS 15 ELIZABETH DRIVE, CHEMSFORD MA 01824
David Jarzynka officer: Sr. VP, General Manager 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Robin Vacha officer: SVP, GM BLS-Products 15 ELIZABETH DRIVE, 15 ELIZABETH DRIVE, CHELMSFORD MA 01824